3LL and 4T1 Tumors

A Schematic diagram of 4T1 tumor treatment. The...

4T1 Syngeneic Breast Tumor Mouse Model I Precli...

Inhibition of metastatic tumors on 4T1 breast t...

Evaluation of the therapeutic effect on 4T1 tum...

In vivo 4T1 solid tumor treatment. (A) Images o...

Dimensions, morphometry, and histology of 4T1 t...

Cell viability of 4T1 cells in 3D mixed tumor s...

ICS I suppresses tumor growth in the 4T1 breast...

Inhibition of metastasis of 4T1 cancer to TDLN ...

The comparison in the measurement of 4T1 tumour...

(a) Schematic illustration of the 4T1 tumor est...

In vivo collagen features in 3LL and 4T1 tumors...

a) Schematic illustration of the treatments in ...

| Tumor growth. (A) Tumor weight from control (...

In vivo collagen features in 3LL and 4T1 tumors...

Histological features of 3LL tumors. A, untreat...

Changes in vasculature of 4T1 tumors after ICI ...

In vivo antitumor efficacy in 4T1 tumors. (A) T...

A The viability of 4T1 cells after different tr...

Protection from 4T1 tumor rechallenge in treate...

Mammary tumors developed in all 4T1-injected an...

In vivo antitumor evaluation in the 4T1 tumor m...

In vivo collagen features in 3LL and 4T1 tumors...

LM.4T1 tumors are highly inflammatory with incr...

Fig. 3 Minimal treatment of ETL decreases metas...

a) Volume changes of 4T1 tumors receiving diffe...

Profile and composition of circulating lipoprot...

(A) 4T1 tumors collected on Day 15 upon differe...

Antitumor performance on 4T1 tumor model. (a) T...

a) Treatment timeline from 4T1 tumor inoculatio...

Tumor volumes were measured at 3 days, 1 week, ...

(a) ER, PR and HER-2 negative and lung metastas...

Antitumor effect study in 4T1 tumor models. A D...

4T1 breast cancer cells cultured on a 3D model ...

4T1, TS/A, and AT3 mammary tumors induce Gr1 ؉ ...